Arthroscopic rotator cuff repair
Conditions
Interventions
group PCSA:In PCNA group, suprascapular nerve puncture tube was inserted and controlled analgesia pump was connected. The formulated drug was 0.3% ropivacaine 300mI, the background infusion dose was s
group PCIA:In the PCIA group, intravenous controlled analgesia pump was connected after surgery, sufentanil citrate 2.5ug/kg, dexmetomidine 1ug/kg, remosetron 0.6mg,diluted with normal saline to 150ml
Sponsors
Guang 'an People's Hospital
Eligibility
Sex/Gender
All
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Age 45-60 years old; (2) Elective arthroscopic rotator cuff repair; (3)ASA physical status I–II; (4) Agree to anesthesia and postoperative analgesia plan; (5) Sign informed consent for anesthesia.
Exclusion criteria
Exclusion criteria: (1) Shoulder revision surgery; (2) Infection at the puncture site in the neck, deformity of the neck, history of neck surgery; (3) History of shoulder and arm movement and sensation abnormalities due to cervical spine disease or cerebral infarction; (4) Uncontrolled hypertension or diabetes; (5)Diabetic peripheral neuropathy;(6) Severe cardiopulmonary function impairment, liver or kidney dysfunction, or coagulation disorders; (7) Unconsciousness or mental abnormalities that prevent cooperation with the procedure; (8) Allergic to ultrasound coupling agents, local anesthetics, or opioid drugs; (9) Long-term oral administration of opioid analgesic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity NRS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory index detection;Adverse analgesic reaction;Evaluation of shoulder joint mobility function; | — |
Countries
China
Contacts
Public ContactSulan Qin
Guang 'an People's Hospital
Outcome results
None listed